Bausch Health Companies | VRX - Operating Profit

Stock Price
7.77
Daily Change
0 0%
Monthly
-23.90%
Yearly
-26.28%
Q1 Forecast
7.62

Bausch Health Companies reported $717M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Amgen USD 3.96B 464M Dec/2025
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
Bausch Health Companies USD 717M 260M Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Canopy Growth CAD -14.3M 3.18M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Drreddys Laboratories INR 14.33B 2.51B Dec/2025
Eli Lilly USD 8.39B 1.37B Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Prestige Brands USD 79.67M 7.91M Sep/2025
Supernus Pharmaceuticals USD -60.18M 72.32M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025
Zoetis USD 936M 63M Sep/2025